Derek R. Duckett

5.1k total citations · 1 hit paper
71 papers, 3.6k citations indexed

About

Derek R. Duckett is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Derek R. Duckett has authored 71 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in Derek R. Duckett's work include Melanoma and MAPK Pathways (12 papers), DNA and Nucleic Acid Chemistry (11 papers) and Cancer-related Molecular Pathways (9 papers). Derek R. Duckett is often cited by papers focused on Melanoma and MAPK Pathways (12 papers), DNA and Nucleic Acid Chemistry (11 papers) and Cancer-related Molecular Pathways (9 papers). Derek R. Duckett collaborates with scholars based in United States, United Kingdom and Germany. Derek R. Duckett's co-authors include David M.J. Lilley, Alastair I.H. Murchie, Michael D. Cameron, Eberhard von Kitzing, Börries Kemper, Paul Modrich, William Roush, Robert M. Clegg, Stephan Diekmann and Andrii Monastyrskyi and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Derek R. Duckett

68 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1

2011 338 citations Wayne Grant, Derek R. Duckett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Derek R. Duckett United States	30	2.7k	623	372	339	277	71	3.6k
Matthew Elliott United States	16	1.8k 0.7×	457 0.7×	324 0.9×	161 0.5×	143 0.5×	32	2.7k
Ricardo M. Biondi Germany	31	3.4k 1.2×	329 0.5×	276 0.7×	265 0.8×	340 1.2×	79	4.1k
Hilary McLauchlan United Kingdom	13	3.2k 1.2×	775 1.2×	303 0.8×	324 1.0×	298 1.1×	16	4.6k
Tyzoon Nomanbhoy United States	25	2.3k 0.9×	582 0.9×	449 1.2×	161 0.5×	152 0.5×	47	3.3k
Stephen V. Frye United States	43	3.5k 1.3×	583 0.9×	877 2.4×	194 0.6×	190 0.7×	159	5.6k
Pamela A. Benfield United States	31	2.4k 0.9×	556 0.9×	379 1.0×	101 0.3×	140 0.5×	39	4.0k
Shi‐Chung Ng United States	29	3.2k 1.1×	790 1.3×	352 0.9×	132 0.4×	212 0.8×	41	4.0k
Susanne Schiffmann Germany	30	2.2k 0.8×	317 0.5×	178 0.5×	194 0.6×	207 0.7×	80	3.5k
Aldo Jongejan Netherlands	31	1.7k 0.6×	321 0.5×	251 0.7×	117 0.3×	171 0.6×	129	3.4k
Hervé Coste France	16	3.5k 1.3×	465 0.7×	391 1.1×	97 0.3×	278 1.0×	17	4.8k

Countries citing papers authored by Derek R. Duckett

Since Specialization

Citations

This map shows the geographic impact of Derek R. Duckett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek R. Duckett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek R. Duckett more than expected).

Fields of papers citing papers by Derek R. Duckett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek R. Duckett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek R. Duckett. The network helps show where Derek R. Duckett may publish in the future.

Co-authorship network of co-authors of Derek R. Duckett

This figure shows the co-authorship network connecting the top 25 collaborators of Derek R. Duckett. A scholar is included among the top collaborators of Derek R. Duckett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek R. Duckett. Derek R. Duckett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Padmanabhan, Jaya, Patrick T. Grogan, Derek R. Duckett, et al.. (2025). STEM-16. COMBINATION THERAPIES WITH CDK9 INHIBITORS AS A PROMISING STRATEGY TO OVERCOME THERAPY RESISTANCE IN GLIOBLASTOMAS. Neuro-Oncology. 27(Supplement_5). v81–v81.

González‐Rodríguez, María, Scott Troutman, Simon Bayle, et al.. (2024). Synergistic effects of combined BET and FAK inhibition against Vestibular Schwannomas in NF2-related Schwannomatosis. Oncogene. 43(40). 2995–3002. 3 indexed citations

Schmitz, Maximilian, Solomon Tadesse, Vinayak Palve, et al.. (2024). Discovery and design of molecular glue enhancers of CDK12–DDB1 interactions for targeted degradation of cyclin K. RSC Chemical Biology. 6(1). 36–55. 3 indexed citations

Bayle, Simon, et al.. (2023). Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties. European Journal of Medicinal Chemistry. 266. 116101–116101. 3 indexed citations

Schmitz, Maximilian, Ines H. Kaltheuner, K. Anand, et al.. (2023). The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation. Journal of Biological Chemistry. 300(1). 105501–105501. 6 indexed citations

Liu, Xiang, Bo Zhao, Timothy I. Shaw, et al.. (2022). Summarizing internal dynamics boosts differential analysis and functional interpretation of super enhancers. Nucleic Acids Research. 50(6). 3115–3127. 5 indexed citations

Chen, Zhihua, Jiannong Li, Eslam Mohamed, et al.. (2021). Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity. Cancer Immunology Research. 9(5). 554–567. 19 indexed citations

Law, Vincent, Ganesan Ramamoorthi, Krithika N. Kodumudi, et al.. (2021). A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease. Journal of Visualized Experiments. 5 indexed citations

Vena, Francesca, Simon Bayle, Ainhoa Nieto, et al.. (2020). Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase. Molecular Cancer Therapeutics. 19(8). 1623–1635. 8 indexed citations

10.

Quereda, Víctor, Shurong Hou, Franck Madoux, et al.. (2018). A Cytotoxic Three-Dimensional-Spheroid, High-Throughput Assay Using Patient-Derived Glioma Stem Cells. SLAS DISCOVERY. 23(8). 842–849. 25 indexed citations

11.

Sturchler, Emmanuel, Wei‐Min Chen, Timothy Spicer, et al.. (2014). Development of an HTS-Compatible Assay for the Discovery of ASK1 Signalosome Inhibitors Using AlphaScreen Technology. Assay and Drug Development Technologies. 12(4). 229–237. 2 indexed citations

12.

He, Yuanjun, Derek R. Duckett, Wei‐Min Chen, et al.. (2013). Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(1). 161–164. 19 indexed citations

13.

Bibian, Mathieu, Ronald J. Rahaim, Jun Yong Choi, et al.. (2013). Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties. Bioorganic & Medicinal Chemistry Letters. 23(15). 4374–4380. 63 indexed citations

14.

Weiser, Amiee, et al.. (2010). A Predictive Nuclear Translocation Assay for Spliced X-Box–Binding Protein 1 Identifies Compounds with Known Organ Toxicities. Assay and Drug Development Technologies. 9(1). 79–87. 4 indexed citations

15.

Shin, Youseung, Wei‐Ming Chen, Jeff E. Habel, et al.. (2009). Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(12). 3344–3347. 24 indexed citations

16.

Kamenecka, Ted, Jeff E. Habel, Derek R. Duckett, et al.. (2009). Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38. Journal of Biological Chemistry. 284(19). 12853–12861. 58 indexed citations

17.

Chen, Yen‐Ting, Thomas D. Bannister, Amiee Weiser, et al.. (2008). Chroman-3-amides as potent Rho kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(24). 6406–6409. 45 indexed citations

18.

Giraud‐Panis, Marie‐Josèphe, Derek R. Duckett, & David M.J. Lilley. (1995). The Modular Character of a DNA Junction-resolving Enzyme: A Zinc-binding Motif in Bacteriophage T4 Endonuclease VII. Journal of Molecular Biology. 252(5). 596–610. 24 indexed citations

19.

Duckett, Derek R., et al.. (1995). Binding of the Junction-resolving Enzyme Bacteriophage T7 Endonuclease I to DNA: Separation of Binding and Catalysis by Mutation. Journal of Molecular Biology. 246(1). 95–107. 64 indexed citations

20.

Duckett, Derek R. & David M.J. Lilley. (1991). Effects of base mismatches on the structure of the four-way DNA junction. Journal of Molecular Biology. 221(1). 147–161. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact